Skip to content

R&D and partnerships

R&D partnerships

An extension of your bench, not a black box. Our own research stays on our platforms. For an outsourced or partnership program with you, a PhD-level project lead runs it and the project’s partners follow it live in a shared R&D board.

CIR-approved 2026–2028
5
ready-made programs to build on
1
contract, 1 project lead, partners included
2
business days to reply to your request
Our platforms and teams Marseille 010203 Internal R&DprogramsOutsourced R&DprogramsCollaborative &strategic partnershipprograms Internal only, not shared Partner portalshared board

Three formats

Choose the depth of engagement

Same team, same laboratories. 01 stays internal; 02 and 03 are followed in the partner portal. What changes is who the question belongs to and how much we build together.

01 · Own research

Internal R&D programs

Our own research: methods we develop and validate ourselves before offering them.

  • Run end to end by our team, on our platforms
  • They become the Xplorer™ programs and 360 offers
  • Not shared: no portal and no shared board, progress, data and results stay with us. Co-developing means moving to 02 or 03
02 · Entrusted to us

Outsourced R&D programs

Your R&D, entrusted to GENXMAP and run by a PhD-level project lead.

  • Protocol, deliverables and work split co-designed with your team
  • Interim results, not one report at the end
  • Followed by you in the R&D partner portal, on a shared board
03 · Co-development

Collaborative & strategic partnership programs

Co-developed with laboratories and industrial partners: shared milestones and costs, often multi-year.

  • Shared roadmap, governance, milestones and costs
  • Consortium built through our network
  • Support with funding applications
  • Followed in the same partner portal

Why it works

Where outsourced R&D usually breaks down

A CRO delivers throughput on a fixed ticket. An academic lab brings depth, on its own calendar. We sit between the two.

Typical CRO

  • Fixed scope, little scientific dialogue
  • A black box between order and report
  • Little room to adapt mid-project

Typical academic collaboration

  • Deep science, slower timelines
  • Capacity tied to lab and student availability
  • Publication cycles that outlast your roadmap
GENXMAP

An extension of your bench

  • A dedicated PhD-level project lead, one contact
  • Scope that adapts: one experiment or a multi-month program
  • Wet lab, bioinformatics and AI in one workflow
  • Regular checkpoints, shared live in the portal

R&D partner portal

One shared board per project, live, for its partners

Each project’s partners work from the same project sheet, each according to their rights. No status emails to chase.

  • One shared R&D boardProjects and work packages, progress against plan, at a glance.
  • Who does whatThe work split by organization, and which deliverables are due, delivered or pending.
  • Shared milestones and costsNext milestones, the budget and each partner sees their own share of costs.
  • Exchanges and documentsMessages within each project, joint files in one access-controlled space.
R&D partner portal: the shared sheet of a Cosmetics 360 project on anti-aging efficacy in ex vivo skin explants, with progress bars, upcoming milestone, experiments by status, monthly activity and partner organizations. Fictional data.R&D partner portal: the shared sheet of a Cosmetics 360 project on anti-aging efficacy in ex vivo skin explants, with progress bars, upcoming milestone, experiments by status, monthly activity and partner organizations. Fictional data.
Real portal screen · fictional data

Building blocks

Programs you can build on

A partnership rarely starts from a blank page. Our programs are designed, documented and ready to be assembled into a larger study.

Underneath

In Marseille: genomics, bulk RNA-seq, proteomics on site on a timsTOF Pro 2, metabolomics and bioinformatics. Through Transcriptomics 360: single-cell and spatial transcriptomics.

Platforms

How it works

From question to answer, without an RFP cycle

  1. 01

    Scoping call

    We reply within 2 business days and start from your question, not a catalog.

  2. 02

    Co-design

    Protocol, deliverables and work split agreed with your team, under mutual NDA.

  3. 03

    Embedded execution

    Your project lead runs the work as an extension of your own bench.

  4. 04

    Checkpoints

    Interim results in the portal, on a cadence that matches yours.

  5. 05

    Iterate or scale

    Adjust the scope, extend the study, or move to a collaborative partnership program.

Who it is for

Academic and hospital labs

Extra wet lab or bioinformatics capacity for a funded project, without recruiting.

Biotech, pharma and cosmetics R&D

Specialized multi-omics and AI for a defined study, without a long procurement cycle.

Translational research groups

One partner from clinical samples to wet lab and computational reading.

Collaborative & strategic partnership programs

Building research programs, and the funding to run them

Beyond single studies, we co-develop with laboratories and industrial partners and act as the scientific and technical anchor of multi-partner programs, with shared milestones and costs, from the shared question to the funding application.

Where we can anchor a consortium

  1. 01
    Single-cell and spatial multi-omics for precision oncologyTumor heterogeneity and treatment response, with our single-cell and spatial partners.
  2. 02
    Host–pathogen and microbiome multi-omicsCombined host and microbial profiling, in the IHU Méditerranée Infection environment.
  3. 03
    AI-driven multi-omics integrationCross-cohort, cross-omics models on reproducible, versioned pipelines.
  4. 04
    Cell and gene therapy bioprocess characterizationMolecular QC methods that travel across partner sites.
Funding support

We help build the application

Call
Identify the scheme that fits: regional, national (Bpifrance, France 2030, ANR) or European.
Application
Scientific work packages, budget per partner, timeline and deliverables, written with you.
Consortium
Complementary partners through our network: IHU Méditerranée Infection, Marseille Medical Genetics, Eurobiomed and our clusters.
Experience
We have structured and run a program backed by Bpifrance and France 2030.

We do not promise an amount, a success rate or a tax credit: the decision belongs to the funder.

Research tax credit (CIR)

CIR-approved research organization, 2026–2028

Our R&D work can be included in your research tax credit (CIR): GENXMAP is a CIR-approved research organization for 2026–2028. Eligibility is assessed project by project; we describe the R&D operations precisely on our invoices to make your filing easier.

Approval
GENXMAP is approved under article 244 quater B, II d bis of the French tax code (CGI) as an organization carrying out R&D work on behalf of companies, for the years 2026 to 2028 (decision of the French Ministry of Higher Education, Research and Space, DGRI).
What it changes
The approval recognises our capacity to carry out R&D for clients. It lets you include the R&D work you entrust to us in your CIR file, if the project is eligible.
Before the quote
Tell us at scoping whether you plan to claim the CIR, so the work packages and the description of the operations are written accordingly.
On the invoice
The R&D operations are described precisely on our invoices.
Supporting documents
We provide the approval decision and the detailed invoices.
Eligibility
The approval does not by itself establish that a project is eligible: this is assessed case by case. Please confirm with your chartered accountant. We do not guarantee eligibility or any amount.

Confidentiality

Your data stays yours

Security and confidentiality are set before the first exchange of project detail, not after.

NDA
Mutual NDA available before any project detail is shared, at no charge.
Hosting
Data hosted in the EU, backups in France, a separate space per partner.
AI
Models on our own servers, no data sent to an external AI.
Partners
A vetted partner performing a step works under a confidentiality or data processing agreement.
Reports
PDF with a verifiable, time-stamped fingerprint.

See the terms and the privacy policy.

FAQ

Questions we get asked

Choosing a format

What is the difference between outsourced R&D and a partnership program?

In an outsourced R&D program you entrust a defined study to GENXMAP: one PhD-level project lead, followed by you in the partner portal. In a collaborative and strategic partnership program we co-develop with partners (laboratories, industrial companies): a shared roadmap, shared milestones and costs, often multi-year and with public funding.

Direct link to this question
Are your internal R&D programs shared with partners?

No. Internal R&D programs run on our own platforms, with no portal and no shared board: progress, data and results stay with us. To co-develop, we move to a collaborative partnership program, where the roadmap, milestones and costs are shared and followed in the partner portal.

Direct link to this question
Do I need a formal RFP to start?

No. We reply within 2 business days, then hold a scoping call, co-design the protocol and execute with regular checkpoints shared live in the portal, without a formal RFP cycle. A dedicated PhD-level project lead is your single contact throughout.

Direct link to this question

Running and funding

Can we follow the project ourselves?

Yes. The R&D partner portal shows the shared board, who does what, milestones and each partner’s own share of costs, which only that partner sees. Checkpoints are shared live there, and you decide which colleagues have access and what each of them sees.

Direct link to this question
Can you help us fund a program?

Yes. We help choose the call, write the work packages, set the budget per partner and the timeline, and find complementary partners. We do not promise an amount or a success rate. Collaborative programs are often multi-year and backed by public funding, with shared milestones and costs.

Direct link to this question
Can your R&D work count toward our research tax credit (CIR)?

Yes, it can be included in your research tax credit (CIR): GENXMAP is a CIR-approved research organization for 2026–2028. Eligibility is assessed project by project and no amount is promised. We describe the R&D operations precisely on our invoices and provide the approval decision and detailed invoices; please confirm with your chartered accountant.

Direct link to this question

Capabilities and data

Do you run single-cell, spatial and proteomics yourselves?

Bulk RNA-seq, genomics and metabolomics run in our Marseille laboratories. Proteomics is performed on a timsTOF Pro 2. Single-cell and spatial transcriptomics are available through Transcriptomics 360, under one GENXMAP contract and one project lead, so an R&D program keeps a single point of contact.

Direct link to this question
Is our partnership data confidential?

Yes. Data is hosted in the EU, with backups in France, in a separate space per partner. A mutual NDA can be signed before any detail is shared, at no charge.

Direct link to this question

Exploring a research partnership?

Tell us the question. We’ll propose the right format.

Reply within 2 business days